Literature DB >> 8352297

Lipid exudation in age-related macular degeneration.

D Lozano-Rechy1, J S Duker, A E Jalkh.   

Abstract

We reviewed the relationship between lipid exudation and subretinal neovascular membranes associated with age-related macular degeneration. The records of 500 consecutive patients with subretinal neovascular membranes caused by age-related macular degeneration were examined. Seventy-five patients (15%) (85 eyes) manifested lipid exudation in conjunction with subretinal neovascularization. Twelve patients (2.4%) (13 eyes) had a massive lipid exudative response with extensive serous retinal detachment (resembling Coats' disease). Of the 85 eyes with subretinal neovascular membranes and lipid exudation, 71 (84%) had a subretinal neovascular membrane that was classified as ill defined. Improvement of vision with or without treatment was seen in only 14 of these 85 eyes (16.4%). After comparing these 85 eyes to 94 eyes from 76 patients with age-related macular degeneration and subretinal neovascular membranes but no lipid exudation, we found that a subretinal neovascular membrane associated with lipid exudation was more likely to be ill defined (71 eyes [84%] vs 35 eyes [37%]; P = .0001), was more frequently associated with retinal pigment epithelial detachment (30 eyes [35%] vs 15 eyes [16%]; P = .0029), and was more likely not to have stabilization of visual acuity (14 eyes [16%] vs 31 eyes [33%]; P = .025).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352297     DOI: 10.1016/s0002-9394(14)71277-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  1 in total

1.  Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; Glenn J Jaffe; Cynthia A Toth; Frederick L Ferris; Daniel F Martin; James Shaffer; Gui-Shuang Ying
Journal:  Ophthalmol Retina       Date:  2017 Jan-Feb
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.